Amyxa Pharmaceuticals to Develop Novel Anti-Influenza Drugs from Marine Microorganisms and Medicinal Plants
Date: 7.2.2006
WOBURN, Mass.--(BUSINESS WIRE)--Jan. 18, 2006--Aphios Corporation today announced the formation of a limited liability subsidiary Amyxa Pharmaceuticals, which will focus on the discovery and development of novel anti-influenza drugs from marine microorganisms and terrestrial plants that are active and protective against different strains of Influenza A including H5N1 viruses and Influenza B.
"Source":[
http://home.businesswire.com/portal/site/biospace/index.jsp?epi-content=GENERIC&newsId=20060118005260&ndmHsc=v2*A1136984400000*B1137635043000*DgroupByDate*G2*J2*N1000122&newsLang=en&beanID=1229976837&viewID=news_view]
